Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 101-108 of 108 for breast cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study of Effect of Megakaryocytes and Platelets in Breast Cancer

    La Crosse, WI

  2. DiviTum Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients

    Jacksonville, FL

  3. Changes in GI Inflammation and the GI Microbiome Profile in Women With Breast Cancer Throughout Chemotherapy

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy

    Jacksonville, FL

  5. Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

    Jacksonville, FL

  6. Establishing a Possible Correlation Between Chest Wall and Breast Lymphedema

    Rochester, MN

  7. Gut and Tumor Microbiome in Patients With Advanced ER-positive and HER2-negative Breast Cancer or Advanced Melanoma Undergoing PD-1 Checkpoint Inhibitor Therapy.

    Jacksonville, FL

  8. Gene Editing Research With a Patient Centered Approach

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer